Abstract
Objectives To understand the long-term mental sequelae for families over the course of the COVID-19 pandemic, the well-being of children with and without complex medical histories and their parents was investigated longitudinally.
Methods Well-being of 200 school-aged children (73 typically-developing, 46 born very preterm, 73 with complex congenital heart disease) and 175 of their parents was assessed prior to and during the first (April–May 2020), second (October–November 2020), and third waves (April–May 2021) of the pandemic with standardized questionnaires. Social and COVID-19-specific determinants were investigated as predictors of impaired well-being.
Results Child proxy-reported well-being was lower than before the pandemic during the first (P<0.001) and third waves (P=0.01) but not the second (P=0.13). Child self-reported well-being was not lower during the pandemic (all P>0.10). Parent well-being dropped during the first wave (P<0.001) and remained low during the first year (P<0.01). One year into the pandemic, 18/25% of children (self-/proxy-report) and 27% of parents scored below the normal range compared to 11%/10%, and 16%, respectively, before the pandemic. Parents of typically-developing children reported lower well-being than parents of children born very preterm (P=0.006) or with a complex congenital heart disease (P=0.03). Child and parent well-being was lower in families with sparse social support (P<0.001) and poor family functioning (P<0.01).
Conclusion The pandemic continues to impact family well-being one year after its outbreak. Families with sparse social support and poor family functioning are particularly at risk for compromised well-being and support should be provided to them.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was financially supported by a grant of the Childrens Research Center, University Childrens Hospital Zurich. The EpoKids study was supported by the Swiss National Science Foundation (grant number 320030_169733). The ReachOut study was supported by the Maexi Foundation Switzerland and the Mercator Foundation Switzerland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics committee of the Canton of Zurich, Switzerland.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
For re-analyzes of the data set (for different purposes), additional ethical approval (on an individual user and purpose basis) will be required. The authors are happy to support additional ethical approval applications from researchers for access to this data set.